Imaging

Teratoma

Preliminary Diagnosis: Teratoma

I. What imaging technique is first-line for this diagnosis

  • Transabdominal or transvaginal ultrasound of the abdomen and pelvis.

II. Describe the advantages and disadvantages of this technique for diagnosis of teratoma.

Advantages

  • Well-validated and well-investigated sonographic features that are diagnostic for teratomas.

  • High sensitivity and very high positive predictive value (100%) when adnexal mass has 2 or more sonographic features known to be associated with teratomas.

  • Cheap and easily accessible.

  • Does not require use of ionizing radiation, and safe in pregnancy and children.

Disadvantages

  • Operator- and viewer-dependent.

  • Certain radiographic features may have overlap with other ovarian conditions, such as endometrioma.

  • Teratomas often have sonographic features that suggest a solid component, which may be mistaken for a solid ovarian mass and suggest malignancy.

  • Unable to fully assess for loco-regional or metastatic disease if malignant.

  • Limited view in obese patients or in patients with unusual abdominal anatomy.

  • Unclear whether transvaginal or transabdominal US is better to assess.

III. What are the contraindications for the first-line imaging technique?

  • There are no major contraindications to ultrasound of the abdomen/pelvis.

IV. What alternative imaging techniques are available?

  • CT of the abdomen and pelvis with IV contrast

  • MRI of the abdomen and pelvis with IV contrast

  • FDG-PET.

V. Describe the advantages and disadvantages of the alternative techniques for diagnosis of teratoma.

CT of the abdomen and pelvis with IV contrast

Advantages

  • Excellent sensitivity for detection of fat and calcifications, which are present in most teratomas.

  • May be more beneficial in assessing other less common teratoma sub-types such as immature cystic and monodermal teratomas.

  • May provide better anatomy and characterization of teratoma and, if malignant, assess for loco-regional and/or metastatic spread.

  • Not operator-dependent.

Disadvantages

  • More expensive than ultrasound.

  • Limited ability to identify teratomas if fat not present.

  • Involves exposing the patient to ionizing radiation.

  • Involves the use of iodinated contrast.

MRI of the abdomen and pelvis with IV contrast

Advantages

  • Highly sensitive for identifying fat and calcifications, which are present in most teratomas.

  • Use of different MRI techniques increases the ability to distinguish fat (teratoma) from hemorrhagic cysts (endometrioma).

  • Better visualization of the anatomy of the teratoma and surrounding tissue. If malignant, better able to assess for local and metastatic spread.

Disadvantages

  • Requires the use of IV contrast.

  • Expensive

  • Limited accessibility in certain medical centers.

  • Not well-tolerated in obese patients, claustrophobic patients, or those with inability to hold breath.

  • Time-consuming

FDG-PET

Advantages

  • There are no advantages to the use of PET versus the imaging modalities described above.

Disadvantages

  • Expensive and not easily accessible.

  • Not well-studied or well-validated.

  • Limited in its ability to distinguish malignant processes from inflammatory conditions.

  • No reports on the behavior of teratomas with FDG-PET scanning.

VI. What are the contraindications for the alternative imaging techniques?

CT of the abdomen and pelvis with IV contrast

  • Contraindicated in pregnant patients

  • Contraindicated in patients with iodine allergies

  • Contraindicated in patients with renal insufficiency

MRI of the abdomen and pelvis with IV contrast

  • Contraindicated in patients with pacemakers, and patients with other implantable, MRI-incompatible devices

  • Contraindicated in patients with chronic renal failure.

FDG-PET

  • There are no major contraindications to this imaging modality.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters